HOSPITAL UNIVERSITARIO INFANTA SOFÍA
Departamento
Hospital de Móstoles
Móstoles, EspañaPublicaciones en colaboración con investigadores/as de Hospital de Móstoles (27)
2023
-
Correction to: Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis (Ophthalmology and Therapy, (2023), 12, 2, (1045-1055), 10.1007/s40123-023-00654-8)
Ophthalmology and Therapy
-
POS0652 Interobserver Reliability and Sensitivity to Change of a Composite Ocular Inflammatory Activity Index: Uvedai
Annals of the Rheumatic Diseases, Vol. 82, Núm. Suppl 1, pp. 604-605
-
Validation of UVEDAI: An Index for Evaluating the Level of Inflammatory Activity in Uveitis
Ophthalmology and Therapy, Vol. 12, Núm. 2, pp. 1045-1055
2022
-
Manifestations and clinical phenotypes are not specific enough to predict SARS-CoV-2 infection in symptomatic children
Acta Paediatrica, International Journal of Paediatrics, Vol. 111, Núm. 10, pp. 1974-1977
-
Oral saliva swab reverse transcription PCR for Covid-19 in the paediatric population
Archives of Disease in Childhood, Vol. 107, Núm. 11, pp. 1051-1058
2021
-
Measuring Choroid Thickness as a Marker of Systemic Inflammation in Patients with Ankylosing Spondylitis
Journal of Clinical Rheumatology, Vol. 27, Núm. 8, pp. E307-E311
2020
-
AB0726 Choroidal Thickness Is a Biomarker a and Can Predict The Response to Treatment in Ankylosing Spondylitis
Annals of the Rheumatic Diseases, Vol. 79, Núm. Suppl 1, pp. 1657.1-1658
-
Choroidal Thickness Is a Biomarker Associated With Response to Treatment in Ankylosing Spondylitis
JCR: Journal of Clinical Rheumatology
-
Epidemiological update on SARS-CoV-2 infection in Spain. Comments on the management of infection in pediatrics
Anales de Pediatria, Vol. 92, Núm. 4, pp. 239-240
2019
-
Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases
Arthritis and Rheumatology, Vol. 71, Núm. 12, pp. 2081-2089
2018
2017
-
Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the largest impact of the flow of migrants today
Clinical and Experimental Rheumatology, Vol. 35, Núm. 5, pp. 752-765
-
The effect of smoking on clinical and structural damage in patients with axial spondyloarthritis: A systematic literature review
Seminars in Arthritis and Rheumatism, Vol. 46, Núm. 5, pp. 569-583
2016
-
Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome
Critical Care, Vol. 20, Núm. 1
2015
2014
-
Performance of the Assessment of Spondyloarthritis International Society criteria for the classification of spondyloarthritis in early spondyloarthritis clinics participating in the ESPERANZA programme
Rheumatology (United Kingdom), Vol. 53, Núm. 2, pp. 353-360
-
Validity of the Ankylosing Spondylitis Disease Activity Score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme
Annals of the Rheumatic Diseases, Vol. 73, Núm. 7, pp. 1350-1355
2013
-
Comparación de 2 estrategias de derivación en el diagnóstico de la espondiloartritis axial en España. Estudio RADAR
Reumatologia Clinica, Vol. 9, Núm. 6, pp. 348-352
2011
-
Community-acquired respiratory coinfection in critically III patients with pandemic 2009 influenza A(H1N1) virus
Chest, Vol. 139, Núm. 3, pp. 555-562
-
Impact of obesity in patients infected with 2009 influenza A(H1N1)
Chest, Vol. 139, Núm. 2, pp. 382-386